Gossamer Bio, Inc. — Director's Dealing 2021

Sep 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2021-09-16

Reporting Person: Giraudo Bryan (COO/CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-16	Stock Option (Right to Buy)	$10.54	A	150000	Acquired	2031-09-16	Common Stock (150000.0)	Direct

Footnotes

F1: 25% of the total number of shares subject to the option will vest on September 16, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date